Neptune Announces Decision of Nasdaq Hearings Panel To Delist Common Shares
Neptune Announces Decision of Nasdaq Hearings Panel To Delist Common Shares
LAVAL, QC / ACCESSWIRE / March 6, 2024 / Neptune Wellness Solutions Inc. ("Neptune" or the "Company") (NASDAQ:NEPT), today announced an update on the status of its appeal against the determination of the Listing Qualifications Staff of The Nasdaq Stock Market LLC ("Nasdaq") to delist the Company's common shares ("Common Shares").
QC LAVAL /ACCESSWIRE/2024年3月6日/海王星健康解决方案公司(“海王星” 或 “公司”)(纳斯达克股票代码:NEPT)今天宣布了其对纳斯达克股票市场有限责任公司(“纳斯达克”)上市资格工作人员决定将公司普通股(“普通股”)退市的上诉的最新情况。
As previously disclosed, the Company had been notified by Nasdaq on November 30, 2023 that it was not in compliance with the minimum bid price requirement for continued listing on the Nasdaq Capital Market (NASDAQ Listing Rule 5550(a)(2)), as the bid price for the Common Shares on Nasdaq closed below US$1.00 for 30 consecutive trading days and that it was not in compliance with the minimum stockholders' equity requirement (NASDAQ Listing Rule 5550(b)(1)), as the Company's stockholders' equity was below the minimum US$2.5 million required for continued listing. The Company submitted a request for a hearing to the to the Nasdaq Hearings Panel (the "Panel") to appeal the delisting determination.
正如先前披露的那样,纳斯达克已于2023年11月30日通知该公司,该公司未遵守继续在纳斯达克资本市场上市的最低出价要求(纳斯达克上市规则5550(a)(2)),因为纳斯达克普通股的出价连续30个交易日收于1.00美元以下,并且不符合最低股东权益要求(纳斯达克上市规则 5550 (b) (1)),因为该公司的股东权益低于继续上市所需的最低250万美元。该公司向纳斯达克听证小组(“小组”)提交了听证请求,以对除名决定提出上诉。
The Panel hearing took place on February 29, 2024. On March 5, the Company received a written decision of the Panel pursuant to which the Panel upheld the delisting determination and denied the Company's requests for additional time to rectify the deficiencies. The Company has the right to request a review of the Panel Decision from the Nasdaq Listing Council within 15 days from the date of the Panel Decision.
小组听证会于2024年2月29日举行。3月5日,公司收到了该小组的书面决定,根据该决定,该小组维持了除名决定,并驳回了该公司延长时间以纠正缺陷的请求。公司有权在小组决定之日起15天内要求纳斯达克上市委员会对小组决定进行审查。
The trading of the Company's Common Shares on Nasdaq will be suspended as of the opening of business on March 7, 2024. The Company is seeking to have its Common Shares quoted on the OTCQB Venture Market of the OTCMarkets.
自2024年3月7日开业之日起,公司在纳斯达克的普通股交易将暂停。该公司正在寻求将其普通股在OTCQB上市 场外交易市场的风险市场。
About Neptune Wellness Solutions Inc.
Neptune is a consumer-packaged goods company that aims to innovate health and wellness products. Founded in 1998 and headquartered in Laval, Quebec with a United States headquarters in Jupiter, Florida, the company focuses on developing a portfolio of high-quality, affordable consumer products that align with the latest market trends for natural, sustainable, plant-based and purpose-driven lifestyle brands. The company's products are available in more than 29,000 retail locations and include well-known organic food and beverage brands such as Sprout Organics, Nosh, and Nurturme, as well as nutraceuticals brands like Biodroga and Forest Remedies. With its efficient and adaptable manufacturing and supply chain infrastructure, the company can quickly respond to consumer demand, and introduce new products through retail partners and e-commerce channels. Please visit neptunewellness.com for more details.
关于 Neptune 健康解决方案公司
海王星是一家消费品包装公司,旨在创新健康和保健产品。该公司成立于1998年,总部位于魁北克省拉瓦尔,美国总部位于佛罗里达州朱庇特,专注于开发符合天然、可持续、植物和以目的为导向的生活方式品牌的最新市场趋势的高质量、实惠的消费产品组合。该公司的产品在超过29,000个零售点有售,其中包括知名的有机食品和饮料品牌,例如Sprout Organics、Nosh和Nurturme,以及Biodroga和Forest Remedies等营养品品牌。凭借其高效且适应性强的制造和供应链基础设施,该公司可以快速响应消费者需求,并通过零售合作伙伴和电子商务渠道推出新产品。请访问 neptunewellness.com 了解更多详情。
Disclaimer - Safe Harbor Forward-Looking Statements
Statements in this news release that are not statements of historical or current fact constitute "forward-looking statements" within the meaning of applicable securities laws. Such forward-looking statements involve known and unknown risks, uncertainties, and other unknown factors that could cause the actual results of Neptune to be materially different from historical results or from any future results expressed or implied by such forward-looking statements. In addition to statements which explicitly describe such risks and uncertainties, readers are urged to consider statements labeled with the terms "believes", "belief", "expects", "intends", "projects", "anticipates", "will", "should" or "plans" to be uncertain and forward-looking. Forward-looking statements relate to future events or future performance and reflect management's expectations or beliefs regarding future events including, but not limited to, statements with respect to the listing and timing of listing of the Company's common shares on the OTCQB Venture Market of the OTCMarkets. Although the Company believes that the assumptions and factors used in preparing the forward-looking information or forward-looking statements in this news release are reasonable, undue reliance should not be placed on such information and no assurance can be given that such events will occur in the disclosed time frames or at all. The forward-looking statements and information included in this news release are made as of the date of this news release and the Company does not undertake an obligation to publicly update such forward-looking information or forward-looking information to reflect new information, subsequent events or otherwise unless required by applicable securities laws. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this news release. The forward-looking statements contained in this news release are expressly qualified in their entirety by this cautionary statement and the "Cautionary Note Regarding Forward-Looking Information" section contained in Neptune's latest Annual Report on Form 10-K and its subsequent filings, which are available on EDGAR at www.sec.gov/edgar.shtml. All forward-looking statements in this news release are made as of the date of this news release. Neptune does not undertake to update any such forward-looking statements whether as a result of new information, future events or otherwise, except as required by law.
免责声明-安全港前瞻性陈述
本新闻稿中非历史或当前事实陈述的陈述构成适用证券法所指的 “前瞻性陈述”。此类前瞻性陈述涉及已知和未知的风险、不确定性和其他未知因素,这些因素可能导致海王星的实际业绩与历史业绩或此类前瞻性陈述所表达或暗示的任何未来业绩存在重大差异。除了明确描述此类风险和不确定性的陈述外,我们敦促读者将标有 “相信”、“信念”、“期望”、“打算”、“项目”、“预期”、“将来”、“应该” 或 “计划” 等术语的陈述视为不确定和具有前瞻性的陈述。前瞻性陈述与未来事件或未来业绩有关,反映了管理层对未来事件的预期或信念,包括但不限于有关公司普通股在场外交易市场的OTCQB风险投资市场上市和上市时间的陈述。尽管公司认为在本新闻稿中准备前瞻性信息或前瞻性陈述时使用的假设和因素是合理的,但不应过分依赖此类信息,也无法保证此类事件将在披露的时间范围内或根本无法保证此类事件会发生。本新闻稿中包含的前瞻性陈述和信息自本新闻稿发布之日起作出,除非适用的证券法要求,否则公司没有义务公开更新此类前瞻性信息或前瞻性信息以反映新信息、后续事件或其他情况。提醒读者不要过分依赖这些前瞻性陈述,这些陈述仅代表截至本新闻发布之日。本警示声明和海王星最新的10-K表年度报告及其后续文件中包含的 “关于前瞻性信息的警示说明” 部分对本新闻稿中包含的前瞻性陈述进行了明确的全面限定,这些报告可在EDGAR上查阅,网址为www.sec.gov/edgar.shtml。本新闻稿中的所有前瞻性陈述均自本新闻发布之日起作出。除非法律要求,否则海王星不承诺更新任何此类前瞻性陈述,无论是由于新信息、未来事件还是其他原因。
Going Concern
As of the date this press release, there is minimal cash balance at the Company. The Company requires funding in the very near term in order to continue its operations and is considering all strategic alternatives that may be available, including debt financing and asset divestitures, in order to generate cash to fund operations. The Company's lack of cash resources and current share price may adversely affect its ability to raise new capital, maintain its NASDAQ listing and execute its business strategy. If the Company is unable to obtain funding in the near term, it may have to cease operations and liquidate its assets. These conditions cast substantial doubt about the Company's ability to continue as a going concern.
继续关注
截至本新闻稿之日,该公司的现金余额微乎其微。该公司需要在短期内提供资金才能继续运营,并正在考虑所有可能的战略选择,包括债务融资和资产剥离,以产生现金为运营提供资金。该公司缺乏现金资源和当前股价可能会对其筹集新资金、维持在纳斯达克上市和执行业务战略的能力产生不利影响。如果公司无法在短期内获得资金,则可能不得不停止运营并清算其资产。这些条件使人们对公司继续作为持续经营企业的能力产生了严重怀疑。
Media Contacts:
media@neptunecorp.com
媒体联系人:
media@neptunecorp.com
SOURCE: Neptune Wellness Solutions, Inc.
来源:海王星健康解决方案有限公司